Multiple myeloma is a malignant proliferation of plasma cells which produces diffuse bone marrow infiltration and focal osteolytic deposits? Proliferation of malignant plasma cells may occur as a localised deposit in the bone marrow, as a medullary plasmacytoma. However, if the deposit occurs outside the bone marrow it is termed an extramedullary plasmacytoma. Extraskeletal spread of multiple myeloma most frequently occurs in the spleen, liver, lymph nodes and kidneys.s
Orbital manifestations of multiple myeloma are rare?, 4 -6,9 In 1981, a review of the worldwide literature revealed 50 cases? Bilateral orbital involvement is the rarest subgroup, with only four cited references in the literature. 4 
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The disease can affect the orbit in a number of ways. Most commonly, it presents with unilateral proptosis without pain?,5,6 Although orbital involvement is rare, when it does occur it may be the initial presentation of the systemic disease in up to 75% of cases. 9 The prognosis and treatment regimes for solitary plasmacytoma and multiple myeloma differ.s Therefore it is important to distinguish between them. Solitary plasmacytoma requires only localised treatment and it carries a better prognosis, with a mean survival rate of 8.3 years compared with 20 months for multiple myeloma. 6 Interestingly this case of recurrence of myeloma was not limited to the orbits but at the time of diagnosis the cutaneous infiltration was also noted. This is a rare phenomenon, with only 60 cases recorded in the literature in 1978Y Generally, the onset of the cutaneous plasmacytoma also proves to be a bad prognostic sign, with 50% mortality at 6 monthsY Infectious crystalline keratopathy (ICK) is a rare corneal infection in which the infecting organism, often bacterial commensals found in the normal conjunctival flora, propagates without ulceration between the lamellae of the corneal stroma,l We describe a case of ICK which was observed to spread from a suture track immediately following the removal of the corneal suture, despite the use of prophylactic chloramphenicol. This is the first case to our knowledge where ICK has occurred in a lamellar corneal graft.
Case re p ort
A 68-year-old woman was admitted from the orthopaedic ward of an affiliated hospital suffering from a central corneal perforation in the right eye resulting in a flat anterior chamber. The left eye had a central descemetocoele which was very slightly Seidel positive, She had severe rheumatoid arthritis and was recovering from a left knee replacement. She did not have a history of rheumatoid eye disease. prophylactically. The patient was examined 3 weeks later and a spreading filamentous crystal-like corneal infiltrate was noted originating from the site (Fig. 1, upper) . The patient was asymptomatic and there was no epithelial defect. The anterior chamber was deep and quiet and there was no sign of graft rejection. The diagnosis of ICK was made on the characteristic appearance and the patient was commenced on g.
ciprofloxacin every 2 h, oc. gentamicin q.d.s., and g.
penicillin every 2 h. Superficial keratectomy to identify the organism was considered but, because the patient was very frail and the area of infiltrate small, conservative management with antibiotics was attempted first in the hope that it would cause resolution.
One week later, the stromal infiltrate had disappeared. In its place there was an overlying epithelial defect and a diffuse ciprofloxacin deposit. The g. ciprofloxacin and oc. gentamicin were stopped and g. chloramphenicol every 2 h started. The g. penicillin was continued.
Two weeks later, the cornea had cleared and there was no evidence of infection. Three months later, the cornea remains clear (Fig. 1, lower) .
Comment
In our differential diagnosis, we considered fungal keratitis. However, the needle-like spreading filamentous appearance of the lesion in this case, with the history, made ICK much more likely. Fungal keratitis should always be considered, especially if there is a history of a wooden foreign body or if the patient lives in an agricultural setting. These did not apply in our case. ICK is a rare condition first described by Gorovoy in 1983? It is characterised by a spreading, filamentous, branching, needle-like stromal opacity. It is most commonly observed in penetrating corneal grafts. It has also been reported in cases of disciform keratitis due to herpes Simplex. Long-term use of topical steroids appears to be a common factor. A break in Bowman's membrane appears to be a prerequisite for the organism to be admitted. In our case, infection appears to have occurred down a suture track. 1 • 2
Histologically, pathognomonic features are microbial proliferation between and limited by the corneal lamellae and a remarkable lack of a host immune response. The overlying epithelium is usually intact and the infection is indolent and progressive. Occasionally the histological features of ICK are present without a visible stromal infiltrate. 3 In the largest series,l in 18 patients with unilateral ICK, the most common cause found on culture was Gram-positive cocci (10 cases, 55%). Of these, viridans type streptococci was the most common. Five cases grew Gram-negative rods. Three cases were caused primarily by Candida yeasts. Four cases grew two different isolates.
ICK is often resistant to antibiotic treatment. 'Blind' treatment should be as broad-spectrum as possible, bearing in mind the statistical likelihood of Streptococcus viridans, e.g. penicillin + ciprofloxacin + gentamicin. Another potent combination is gentamicin and vancomycin.
Where 'blind' antibiotics are unsuccessful, a lamellar keratectomy is advised in order to obtain a sample for microbiological culture and histology. With appropriate intensive antibiotics or antifungals, slow resolution of the ICK usually occurs. It has been pointed out that the term 'infectious crystalline keratopathy', first coined by Meisler in 1984, 4 is a misnomer, for the condition is non-infectious and there are no crystals present. The term 'arborescent bacterial keratopathy' has been suggested as an alternative, S but this name has not become popular.
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Solitary choroidal metastasis managed by trans pupillary thermotherapy
The choroid is the most common site of for uveal metastatic deposits and breast carcinoma accounts 47% of all uveal metastases. 1 External beam radiotherapy 2 or episcleral plaque brachytherapy 3 are currently the favoured modalities in the management of such tumours. We describe a patient with a clinically solitary choroidal metastatic tumour that was treated with transpupillary thermotherapy (TTT).
A 46-year-old woman complained of rapidly decreased vision in her right eye within a month. Two years previously she had undergone radical mastectomy followed by systemic chemotherapy and radiotherapy (a) for ductal breast carcinoma. Her visual acuity was 20/40 in the right eye and 20/20 in the left. Examination of the right fundus showed a solitary, yellow-light brown choroidal mass 1.5 mm temporal to the fovea and within the vascular arcades (Fig. la) . There was a shallow serous retinal detachment, which also partly involved the fovea. A-and B-scan ultrasonography showed a 2.2 mm thick, acoustically solid tumour with medium internal reflectivity (Fig. Ib) . A single session of infrared diode laser TTT, using a power setting of 500 mW, 18 overlapping 3 mm spots each for 1 min, was performed. At the end of the treatment the lesion became greyish opaque. Three months later the patient's right visual acuity was 20/20 and the lesion became flat (Fig. 2) . The subretinal fluid resolved completely. Six months later, she maintained the same level of visual acuity with no evidence of recurrence.
Comment
Choroidal metastatic tumours that are inactive or regressed are most often observed. Treatment is usually recommended if the tumour appears active and threatens the vision or continues to grow despite concomitant systemic chemotherapy.l However, as patients with choroidal metastases have a median expected life span of about 9 months, too aggressive an approach is generally avoided?A External beam radiotherapy (EBR) has a proven efficacy in the management of intraocular metastases. A recent study has shown that useful functional vision could be restored or maintained in 58% of cases and the globe could be saved in 98%? Age less than 55 years, tumour size smaller than 15 mm at the base and a visual acuity better than 20/50 were more significantly correlated with positive visual outcome? In the short term, however, 12% of patients develop several complications and dry eye is a significant problem.5 It should also be noted EBR takes 3-4 weeks to complete, which is relatively long considering the life expectancy of these patients. 
